These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 15728300

  • 1. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Cocho D, Belvís R, Martí-Fàbregas J, Molina-Porcel L, Díaz-Manera J, Aleu A, Pagonabarraga J, García-Bargo D, Mauri A, Martí-Vilalta JL.
    Neurology; 2005 Feb 22; 64(4):719-20. PubMed ID: 15728300
    [Abstract] [Full Text] [Related]

  • 2. Acute stroke management in the elderly.
    Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.
    Cerebrovasc Dis; 2007 Feb 22; 23(4):304-8. PubMed ID: 17199089
    [Abstract] [Full Text] [Related]

  • 3. Why are eligible thrombolysis candidates left untreated?
    Hills NK, Johnston SC.
    Am J Prev Med; 2006 Dec 22; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [Abstract] [Full Text] [Related]

  • 4. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators.
    Neurology; 2005 Feb 22; 64(4):654-9. PubMed ID: 15728287
    [Abstract] [Full Text] [Related]

  • 5. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K, Massaro L, Hammer MD.
    Cerebrovasc Dis; 2010 Feb 22; 29(1):57-61. PubMed ID: 19893313
    [Abstract] [Full Text] [Related]

  • 6. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center.
    Hemmen TM, Meyer BC, McClean TL, Lyden PD.
    J Stroke Cerebrovasc Dis; 2008 Feb 22; 17(1):23-5. PubMed ID: 18190817
    [Abstract] [Full Text] [Related]

  • 7. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH, Viereck J, Kase C, Jeerakathil T, Romero R, Mehta SD, Kociol R, Babikian V.
    J Emerg Med; 2005 Oct 22; 29(3):273-7. PubMed ID: 16183445
    [Abstract] [Full Text] [Related]

  • 8. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG, Pettigrew LC, Ryan S.
    Clin Neurol Neurosurg; 2008 May 22; 110(5):451-4. PubMed ID: 18353532
    [Abstract] [Full Text] [Related]

  • 9. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 May 22; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 10. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A, Dzialowski I, Koch R, Gahn G.
    J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668
    [Abstract] [Full Text] [Related]

  • 11. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC, Sung SF, Ong CT, Wu CS, Su YH.
    Acta Neurol Taiwan; 2009 Mar 15; 18(1):14-20. PubMed ID: 19537569
    [Abstract] [Full Text] [Related]

  • 12. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project.
    Brown DL, Lisabeth LD, Garcia NM, Smith MA, Morgenstern LB.
    Neurology; 2004 Dec 28; 63(12):2250-4. PubMed ID: 15623682
    [Abstract] [Full Text] [Related]

  • 13. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC, Chen CH.
    Clin Neurol Neurosurg; 2009 Jul 28; 111(6):562-3. PubMed ID: 19200644
    [No Abstract] [Full Text] [Related]

  • 14. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
    Kappelle LJ, van der Worp HB.
    Ned Tijdschr Geneeskd; 2000 May 27; 144(22):1025-8. PubMed ID: 10850102
    [Abstract] [Full Text] [Related]

  • 15. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E.
    No Shinkei Geka; 2003 Mar 27; 31(3):249-60. PubMed ID: 12684978
    [No Abstract] [Full Text] [Related]

  • 16. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B, Welzen V, Franke C, van Oostenbrugge R.
    Cerebrovasc Dis; 2007 Mar 27; 23(4):294-8. PubMed ID: 17199087
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H, Ogushi Y, Fushimi K, Kobayashi S, Japanese Standard Stroke Registry Study (JSSRS) Group.
    Tokai J Exp Clin Med; 2005 Apr 27; 30(1):49-62. PubMed ID: 15952299
    [Abstract] [Full Text] [Related]

  • 18. Medicine. Stroke--tPA and the clinic.
    Marler JR, Goldstein LB.
    Science; 2003 Sep 19; 301(5640):1677. PubMed ID: 14500967
    [Abstract] [Full Text] [Related]

  • 19. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
    van den Berg JS, de Jong G.
    Acta Neurol Scand; 2009 Sep 19; 120(3):157-60. PubMed ID: 19719807
    [Abstract] [Full Text] [Related]

  • 20. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
    Johnson M, Bakas T.
    J Neurosci Nurs; 2010 Apr 19; 42(2):88-94. PubMed ID: 20422794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.